Halozyme Therapeutics Inc (STU:RV7)
€ 66.76 -1.9 (-2.77%) Market Cap: 7.94 Bil Enterprise Value: 9.54 Bil PE Ratio: 27.41 PB Ratio: 41.12 GF Score: 73/100

Halozyme Therapeutics Inc (STU:RV7) Transcripts

  • 1